Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Effects of l-glutamine supplementation on reducing c-reactive protein (CRP) levels and length of stay in intensive care unit post laparotomy

Daniel, Pontisomaya Parami.




Abstract
Cited by 0 Articles

Backgrounds: Post-laparotomy ICU patients have an average length of stay in the ICU with an average of 7-14 days depending on the procedure and postoperative complications. When the body is sick or injured, glutamine will become "conditionally-essential" which is a condition where a person needs additional food or supplements. Glutamine (Gln) has been shown to have an important function for various organ systems, including the intestines, the immune system, and to maintain acid-base balance. C-reactive protein (CRP) is a sensitive inflammatory marker to assess non-specific inflammatory response and there is an inverse relationship between Gln and CRP levels (r = -0.44, p < 0.05).
Aims: L-Glutamin 20 gram intravenous per day for 3 days can reduce CRP levels and length of stay in ICU of the post-laparotomy patients.
Method: This study used a double-blind randomized clinical trial to compare a group with L-Gln supplementation and without L-Gln supplementation, for laparotomy patients who were treated in the ICU from March to June 2021.
Results: There were 40 patients divided into 2 groups. The statistical analysis results found the difference in CRP levels, p-value

Key words: C-reactive protein, Glutamine, Intensive care unit, length of stay, laparotomy






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.